KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lam Research (LRCX) Depreciation & Amortization (CF): 2009-2025

Historic Depreciation & Amortization (CF) for Lam Research (LRCX) over the last 17 years, with Q3 2025 value amounting to $101.6 million.

  • Lam Research's Depreciation & Amortization (CF) rose 779.36% to $101.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $393.6 million, marking a year-over-year increase of 828.33%. This contributed to the annual value of $386.3 million for FY2025, which is 738.9% up from last year.
  • As of Q3 2025, Lam Research's Depreciation & Amortization (CF) stood at $101.6 million, which was up 779.36% from $98.4 million recorded in Q2 2025.
  • In the past 5 years, Lam Research's Depreciation & Amortization (CF) registered a high of $101.6 million during Q3 2025, and its lowest value of $75.8 million during Q3 2022.
  • For the 5-year period, Lam Research's Depreciation & Amortization (CF) averaged around $88.5 million, with its median value being $89.6 million (2023).
  • Per our database at Business Quant, Lam Research's Depreciation & Amortization (CF) plummeted by 516.19% in 2022 and then surged by 1944.26% in 2023.
  • Lam Research's Depreciation & Amortization (CF) (Quarter) stood at $81.7 million in 2021, then grew by 4.54% to $85.4 million in 2022, then increased by 6.47% to $90.9 million in 2023, then grew by 5.78% to $96.2 million in 2024, then grew by 5.66% to $101.6 million in 2025.
  • Its Depreciation & Amortization (CF) was $101.6 million in Q3 2025, compared to $98.4 million in Q2 2025 and $97.3 million in Q1 2025.